Adriakaim Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$4.31M
- Investors
-
9
Adriakaim General Information
Description
Developer of a nerve stimulation device designed to reduce the transition to chronic heart failure in patients. The company's device offers various treatment methods that utilize the parasympathetic nervous system in conjunction with the human body's natural healing capacities, enabling doctors to stimulate the vagus nerve and reduce the area of myocardial infarction.
Contact Information
Website
www.adriakaim.co.jpCorporate Office
- 101, Hachioji Textile Center Building
- 13-1 Minami-Shinmachi, Hachioji
- Tokyo, 192-0075
- Japan
Corporate Office
- 101, Hachioji Textile Center Building
- 13-1 Minami-Shinmachi, Hachioji
- Tokyo, 192-0075
- Japan
Adriakaim Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series B) | 15-Jun-2023 | $4.31M | Completed | Generating Revenue | ||
| 6. Early Stage VC | 13-Sep-2021 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 04-Aug-2020 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 18-Nov-2019 | Completed | Generating Revenue | |||
| 3. Seed Round | 25-Feb-2019 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2019 | Completed | Startup | |||
| 1. Accelerator/Incubator | 01-Jan-2019 | Completed | Startup |
Adriakaim Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| C Preferred Shares | ||||||||
| B Preferred Shares | ||||||||
| A Preferred Shares | 2,510 | $455.84 | $455.84 | 1x | $455.84 | 9.82% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Adriakaim Patents
Adriakaim Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2021112506-A | Nerve stimulation apparatus and nerve stimulation method | Pending | 21-Jan-2020 | ||
| US-20210220648-A1 | Nerve stimulation apparatus and nerve stimulation method | Inactive | 21-Jan-2020 | ||
| US-20130238057-A1 | Nerve stimulating device | Active | 28-Oct-2010 | ||
| US-20130110208-A1 | Electrostimulation system, and electrostimulation electrode assembly and biological implantable electrode therefore | Active | 19-Mar-2010 | ||
| US-9050453-B2 | Electrostimulation system, and electrostimulation electrode assembly and biological implantable electrode therefore | Active | 19-Mar-2010 | A61N1/05 |
Adriakaim Signals
Adriakaim Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Capital Medica Ventures | Corporate Venture Capital | Minority | ||
| FLAG-41 | Venture Capital | Minority | ||
| Screen Holdings | Holding Company | Minority | ||
| 360ip Japan | Venture Capital | Minority | ||
| CEJ Capital | Corporate Venture Capital | Minority |
Adriakaim FAQs
-
When was Adriakaim founded?
Adriakaim was founded in 2018.
-
Where is Adriakaim headquartered?
Adriakaim is headquartered in Tokyo, Japan.
-
What is the size of Adriakaim?
Adriakaim has 10 total employees.
-
What industry is Adriakaim in?
Adriakaim’s primary industry is Therapeutic Devices.
-
Is Adriakaim a private or public company?
Adriakaim is a Private company.
-
What is the current valuation of Adriakaim?
The current valuation of Adriakaim is .
-
What is Adriakaim’s current revenue?
The current revenue for Adriakaim is .
-
How much funding has Adriakaim raised over time?
Adriakaim has raised $15.4M.
-
Who are Adriakaim’s investors?
Capital Medica Ventures, FLAG-41, Screen Holdings, 360ip Japan, and CEJ Capital are 5 of 9 investors who have invested in Adriakaim.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process